BlackRock, Inc. 13D and 13G filings for ACADIA Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-07 06:04 am Purchase |
2025-01-31 | 13G | ACADIA Pharmaceuticals Inc. ACAD |
BLACKROCK INC BLK |
19,878,746 11.900% |
8,469,528 (+74.23%) |
Filing |
| 2024-01-26 5:25 pm Purchase |
2023-12-31 | 13G | ACADIA Pharmaceuticals Inc. ACAD |
BLACKROCK INC BLK |
11,409,218 6.900% |
1,150,480 (+11.21%) |
Filing |
| 2023-01-31 5:52 pm Purchase |
2022-12-31 | 13G | ACADIA Pharmaceuticals Inc. ACAD |
BLACKROCK INC BLK |
10,258,738 6.300% |
198,426 (+1.97%) |
Filing |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | ACADIA Pharmaceuticals Inc. ACAD |
BLACKROCK INC BLK |
10,060,312 6.300% |
2,302,466 (+29.68%) |
Filing |
| 2020-07-10 10:39 am Sale |
2020-06-30 | 13G | ACADIA Pharmaceuticals Inc. ACAD |
BLACKROCK INC BLK |
7,757,846 4.970% |
-2,481,049 (-24.23%) |
Filing |